Handelsavisen
prelaunch
Companies Healthcare PMDI.PK
PM
PMDI.PK OTC Healthcare Facilities & Services

Pmdi.Pk

$2,49
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-9,6 %
ROE
-36,3 %
Net margin
-9,5 %
Debt / equity
0,06
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

PMDI.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through its operations in healthcare facilities and services.

Business. PMDI.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through its operations in healthcare facilities and services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
BlackRock Institutional Trust Company, N.A.
largest disclosed fund holder
Profitability
-36,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PMDI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PMDI.PK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    PMDI.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through its operations in healthcare facilities and services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    PMDI.PK has a liquidity position characterized by $1.42 million in cash and equivalents, with a current ratio of 1.82, indicating a relatively strong ability to meet short-term obligations. However, the company reported negative operating income of $1.895 million and a net loss of $1.861 million, which suggests operational challenges. The company's debt-to-equity ratio is 0.06, indicating a low level of leverage and a conservative capital structure.

    In terms of profitability, PMDI.PK's return on equity is -36.28%, and its return on assets is -22.37%, both significantly below the industry median for healthcare facilities and services. These metrics suggest that the company is not generating returns that meet the expectations of its equity and asset base.

    The company's revenue is concentrated in a single segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risk if its primary market experiences downturns.

    PMDI.PK's growth trajectory is uncertain, as the company reported a net loss and negative operating income. There are no provided outlook figures for the current or next fiscal year, and the available data does not include historical revenue growth rates to assess long-term trends.

    The risk assessment for PMDI.PK indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash position support the low liquidity risk rating. However, the negative operating and net income suggest potential operational risks that could affect future liquidity.

    Recent events, including filings and transcripts, are not detailed in the available data. The company's financial snapshot does not include specific recent events or disclosures that would provide insight into its current strategic or operational direction.

    Key takeaways
    • PMDI.PK has a strong liquidity position with a current ratio of 1.82 and $1.42 million in cash and equivalents.
    • The company is currently unprofitable, with a net loss of $1.861 million and a return on equity of -36.28%.
    • PMDI.PK maintains a conservative capital structure with a low debt-to-equity ratio of 0.06.
    • The company's revenue is not diversified across segments or geographies, increasing its exposure to market-specific risks.
    • There are no immediate liquidity or dilution risks, but the company's negative operating and net income suggest ongoing operational challenges.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $2,49
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $5.1M
    Net cash
    $1.1M
    Current ratio
    1.8
    Debt / equity
    0.1
    ROA
    -22.4%
    ROE
    -36.3%
    Cash conversion
    -50.0%
    CapEx / revenue
    -0.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-9,6 %Bottom quartile
    Net Margin-9,4 %Bottom quartile
    ROE-36,3 %Bottom quartile
    Capex / Rev-0,4 %Above P75
    D/E0,06Above P75
    Cash Conv-0,50Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • PMDI.PK Market data — financials · 2026-05-29

    Ownership & reference

    Top holders

    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M

    Leadership

    • Brian HullingerPresident, Chief Executive Officer, Director

    Insider activity

    — missing data

    Short positioning

    3.4Kshares short0.0% vs prior
    999.99days to cover
    223fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PMDI.PKCanonical
    OTC · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Capex (YoY) (2024-12-31 vs 2023-12-31): -67.5%Derived (calculated)
    • Cash & equivalents (YoY) (2024-12-31 vs 2023-12-31): -27.9%Derived (calculated)
    • Operating income (YoY) (2024-12-31 vs 2023-12-31): 35.2%Derived (calculated)
    • Total liabilities (YoY) (2024-12-31 vs 2023-12-31): -43.6%Derived (calculated)
    • Cost of revenue (YoY) (2024-12-31 vs 2023-12-31): -8.0%Derived (calculated)
    • Operating cash flow (YoY) (2024-12-31 vs 2023-12-31): 162.8%Derived (calculated)
    • Total assets (YoY) (2024-12-31 vs 2023-12-31): -32.5%Derived (calculated)
    • Gross profit (YoY) (2024-12-31 vs 2023-12-31): -15.6%Derived (calculated)
    • Net income (YoY) (2024-12-31 vs 2023-12-31): 55.2%Derived (calculated)
    • Return on assets (FY 2024-12-31): -22.4%Derived (calculated)
    • Return on equity (FY 2024-12-31): -36.3%Derived (calculated)
    • Current ratio (FY 2024-12-31): 1.82xDerived (calculated)
    • Debt-to-equity (FY 2024-12-31): 0.62xDerived (calculated)
    • R&D expense (YoY) (2024-12-31 vs 2023-12-31): -34.5%Derived (calculated)
    • Shareholders' equity (YoY) (2024-12-31 vs 2023-12-31): -23.1%Derived (calculated)
    • EPS (basic) (YoY) (2024-12-31 vs 2023-12-31): 55.6%Derived (calculated)
    • R&D expense (annual): USD 749KSEC XBRL filing
    • Current assets (annual): USD 4.94MSEC XBRL filing
    • Operating cash flow (annual): USD 929KSEC XBRL filing
    • Cash & equivalents (annual): USD 1.42MSEC XBRL filing
    • Cost of revenue (annual): USD 12.58MSEC XBRL filing
    • Total liabilities (annual): USD 3.19MSEC XBRL filing
    • Shares outstanding (annual): 6.11MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage